Tests On Professional Antiseptics Could Influence Consumer Hand Wash Market
This article was originally published in The Pink Sheet
Executive Summary
Responding to industry's requests, US FDA's rulemaking on six health care personnel antiseptics remaining in the OTC drug monograph is delayed one year to allow firms to demonstrate the ingredients are GRASE. ACI says the research could impact whether ingredients remain available for consumer hand washes.
You may also be interested in...
Freedom Caucus Hit List Includes Antibacterial Soap, Supplement Label Rules
The caucus of 36 conservative Republicans lists 200 rules passed during the Obama administration, or the that president established through executive orders, that it recommends striking altogether or changing to lessen industries' regulatory burden.
FDA Rule Marks Consumer Antibac Soaps A Possible Endangered Species
FDA’s rule “clarifies the mission” for manufacturers of consumer antibacterial soaps, which have a year to demonstrate that they are safe and effective or risk losing the entire OTC drug category.
Consent Decree Orders FDA Action On Triclosan OTC Monographs
A Nov. 21 consent decree sets multiple deadlines over a five-year period to make FDA finalize its OTC topical antimicrobial drug products monograph with respect to triclosan. Under a pair of deadlines of note to triclosan product makers, the agency must publish a tentative final monograph for consumer antiseptic hand-wash products by Dec. 16, with a final monograph due Sept. 15, 2016.